Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Looking at skin can help find and treat serious diseases early.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Different rheumatological diseases can cause specific skin problems.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

3D-printed membranes with smart sensors can greatly improve tissue healing and have many medical applications.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.